BioHarvest Sciences Inc.

and welcome to the BioHarvest Sciences second quarter 2025 corporate update conference call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation as a reminder. This conference is being recorded. Before we begin the formal presentation, I'd like to remind everyone The statements made on today's call and webcast, including those regarding future financial results and industry prospects, are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described on the call. Please refer to the company's regulatory filings for a list of associated risks. and we would also refer you to the company's website for more supporting industry information. In addition, throughout today's call, the company may refer to adjusted EBITDA, a non-IFRS financial measure which it believes provides helpful information to investors about the performance on the business on an ongoing basis. A reconciliation of adjusted EBITDA to its most directly comparable IFRS, financial measure is included in today's earnings release, which is available on BioHarvest website under the investor tabs. On our call today is Chief Executive Officer Elan Sobel and Chief Financial Officer Paul Dicker. I would now like to hand the call over to CEO Elan Sodell.

Elan, the floor is yours.

Thank you, operator, and good morning, everyone.